Enanta Pharmaceuticals
ENTA
ENTA
147 hedge funds and large institutions have $1.1B invested in Enanta Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 42 increasing their positions, 71 reducing their positions, and 14 closing their positions.
Holders
147
Holders Change
-4
Holders Change %
-2.65%
% of All Funds
2.58%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
11
Increased
42
Reduced
71
Closed
14
Calls
$2.92M
Puts
$53K
Net Calls
+$2.87M
Net Calls Change
+$5.26M
Top Buyers
Top Sellers
| 1 |
1
Invesco
Atlanta,
Georgia
|
$6.03M |
| 2 |
AC
2
Armistice Capital
New York
|
$104M |
| 3 |
3
Acadian Asset Management
Boston,
Massachusetts
|
$13.5M |
| 4 |
4
Millennium Management
New York
|
$881K |
| 5 |
5
BlackRock
New York
|
$204M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TI
151
Trexquant Investment
Stamford,
Connecticut
| – | -$350K | -7,958 | Closed |
|
|
6M
152
6 Meridian
Wichita,
Kansas
| – | -$325K | -7,390 | Closed |
|
|
AIM
153
Aigen Investment Management
New York
| – | -$307K | -6,987 | Closed |
|
154
Fisher Asset Management
Camas,
Washington
| – | -$291K | -6,601 | Closed |
|
|
GCP
155
GSA Capital Partners
London,
United Kingdom
| – | -$276K | -6,281 | Closed |
|
|
RA
156
Royce & Associates
New York
| – | -$235K | -5,340 | Closed |
|
157
Squarepoint
New York
| – | -$217K | -4,924 | Closed |
|
|
ECM
158
Everence Capital Management
Goshen,
Indiana
| – | -$210K | -4,780 | Closed |
|